Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
- Princeton Students Awarded Community-Engaged Population Health Microinternships
- Join NJ ACTS Biostatistics, Epidemiology, Research Design for the March 7th Workshop Series
- Case Western Reserve University CTSA hosts Women’s Health Equity Un-Meeting on Wednesday, March 13, 2024
- Road to Commercialization Symposium Series on March 26th
- Rutgers Climate and Energy Institute Workshop on March 21st – Register Today